Stoke Therapeutics Inc (STOK) Insider Trading
- $55,396,431.33
- $95,247,414.93
- Dec. 9, 2024
- Huw M Nash
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Dec. 9, 2024 | Insider | 2,586 | $12.99 | Sell | $33,592.14 | |
Dec. 9, 2024 | General Counsel | 13,666 | $13.61 | Sell | $185,994.26 | |
Dec. 9, 2024 | CEO | 6,786 | $12.99 | Sell | $88,150.14 | |
Dec. 6, 2024 | General Counsel | 9,696 | $12.78 | Sell | $123,914.88 | |
Dec. 6, 2024 | CEO | 6,170 | $12.78 | Sell | $78,852.60 | |
Dec. 6, 2024 | Insider | 13,945 | $12.78 | Sell | $178,217.10 | |
Dec. 2, 2024 | Insider | 10,000 | $12.07 | Sell | $120,700.00 | |
Sept. 19, 2024 | Major Shareholder | 1,937,500 | $14.05 | Sell | $27,221,875.00 | |
July 1, 2024 | Insider | 10,000 | $13.75 | Sell | $137,500.00 | |
April 17, 2024 | Major Shareholder | 3,600,000 | $11.60 | Sell | $41,760,000.00 | |
March 28, 2024 | General Counsel | 5,126 | $13.20 | Sell | $67,663.20 | |
March 19, 2024 | General Counsel | 2,349 | $6.10 | Sell | $14,328.90 | |
March 19, 2024 | CFO | 4,116 | $6.10 | Sell | $25,107.60 | |
March 19, 2024 | CEO | 11,150 | $6.10 | Sell | $68,015.00 | |
Feb. 1, 2024 | Insider | 10,000 | $4.80 | Sell | $48,000.00 | |
Jan. 2, 2024 | Insider | 10,000 | $5.74 | Sell | $57,400.00 | |
July 3, 2023 | Insider | 15,000 | $10.60 | Sell | $159,000.00 | |
June 21, 2023 | General Counsel | 1,948 | $13.48 | Sell | $26,259.04 | |
June 1, 2023 | Insider | 15,000 | $11.13 | Sell | $166,950.00 | |
May 3, 2023 | Insider | 24,697 | $10.14 | Sell | $250,427.58 | |
May 1, 2023 | Insider | 24,967 | $10.00 | Sell | $249,670.00 | |
Feb. 6, 2023 | Insider | 9,235 | $10.02 | Sell | $92,534.70 | |
Feb. 2, 2023 | Insider | 267 | $10.00 | Sell | $2,670.00 | |
Jan. 31, 2023 | Insider | 200 | $10.00 | Sell | $2,000.00 | |
Jan. 3, 2022 | COO | 3,800 | $23.07 | Sell | $87,666.00 | |
Dec. 1, 2021 | COO | 5,700 | $24.44 | Sell | $139,308.00 | |
Nov. 3, 2021 | COO | 1,900 | $25.00 | Sell | $47,500.00 | |
Nov. 1, 2021 | COO | 3,800 | $23.54 | Sell | $89,452.00 | |
Oct. 1, 2021 | COO | 5,700 | $24.83 | Sell | $141,531.00 | |
Sept. 1, 2021 | COO | 5,700 | $26.00 | Sell | $148,200.00 | |
Aug. 2, 2021 | COO | 5,700 | $28.87 | Sell | $164,559.00 | |
July 13, 2021 | Insider | 43,166 | $32.75 | Sell | $1,413,686.50 | |
Feb. 23, 2021 | CFO | 30,000 | $58.86 | Sell | $1,765,800.00 | |
Feb. 19, 2021 | Director | 10,000 | $60.67 | Sell | $606,700.00 | |
Jan. 6, 2021 | COO | 32 | $57.14 | Sell | $1,828.48 | |
Jan. 4, 2021 | COO | 5,700 | $58.97 | Sell | $336,129.00 | |
Dec. 21, 2020 | Insider | 1,365 | $57.62 | Sell | $78,651.30 | |
Dec. 18, 2020 | CEO | 25,000 | $60.00 | Sell | $1,500,000.00 | |
Dec. 18, 2020 | COO | 50,000 | $60.00 | Sell | $3,000,000.00 | |
Dec. 1, 2020 | COO | 5,700 | $49.84 | Sell | $284,088.00 | |
Nov. 27, 2020 | CEO | 12,152 | $50.00 | Sell | $607,600.00 | |
Nov. 25, 2020 | CEO | 12,848 | $50.00 | Sell | $642,400.00 | |
Nov. 24, 2020 | Major Shareholder | 375,000 | $39.00 | Buy | $14,625,000.00 | |
Nov. 23, 2020 | Director | 20,000 | $46.03 | Sell | $920,600.00 | |
Nov. 10, 2020 | COO | 50,000 | $45.00 | Sell | $2,250,000.00 | |
Nov. 4, 2020 | CFO | 70,000 | $39.00 | Sell | $2,730,000.00 | |
Nov. 2, 2020 | CFO | 35,000 | $37.25 | Sell | $1,303,750.00 | |
Nov. 2, 2020 | COO | 5,700 | $37.21 | Sell | $212,097.00 | |
Oct. 19, 2020 | EVP | 32,000 | $37.82 | Sell | $1,210,240.00 | |
Oct. 16, 2020 | EVP | 5,851 | $40.00 | Sell | $234,040.00 |
Insiders are both buying and selling Stoke Therapeutics Inc stock.
The insider traders at Stoke Therapeutics Inc are: Huw M Nash, Barry Ticho, Edward M Md Kaye, Jonathan Allan, Gene Liau, Rtw Investments, Lp, Huw M. Nash, Stephen J. Tulipano, Arthur Tzianabos, Apple Tree Partners Iv, L.P., Skorpios Trust, Stephen J Tulipano, and Robin A. Walker
The most active insider trader at Stoke Therapeutics Inc is Huw M Nash with 19 trades.
Skorpios Trust has sold the most Stoke Therapeutics Inc stock with a total value of $96,203,750.00.
Apple Tree Partners Iv, L.P. has bought the most Stoke Therapeutics Inc stock with a total value of $54,250,002.00.
The most recent insider trade for Stoke Therapeutics Inc was on Dec. 9, 2024.
The single biggest insider buy for Stoke Therapeutics Inc was from Apple Tree Partners Iv, L.P. with a total value of $25,000,002.00 on June 21, 2019.
The single biggest insider sell for Stoke Therapeutics Inc was from Skorpios Trust with a total value of $41,760,000.00 on April 17, 2024.